Surveillance of monthly antimicrobial consumption rates stratified by patient-care area: A tool for triggering and targeting antibiotic policy changes in the Hospital

Journal of Chemotherapy

Volumn 18, Issue 4, 2006, Pages 394-401

  Kritsotakis, E I ^a   Assithianakis, P ^a   Kanellos, P ^a   Tzagarakis, N ^a   Ioannides, M C ^a   Gikas, A ^a  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

Antimicrobial use; ATC DDD methodology; Drug utilization study; Hospital; Surveillance

Indexed keywords

AMINOGLYCOSIDE DERIVATIVE; AMOXICILLIN; AMPICILLIN; ANTIINFECTIVE AGENT; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CARBAPENEM DERIVATIVE; CEFACLOR; CEFADROXIL; CEFAMANDOLE; CEFATRIZINE; CEFEPIME; CEFIXIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; ERYTHROMYCIN; GLYCOPEPTIDASE; IMIDAZOLE DERIVATIVE; LINCOSAMIDE DERIVATIVE; MONOBACTAM DERIVATIVE; PENICILLIN DERIVATIVE; PIPERACILLIN; ROXITHROMYCIN; TETRACYCLINE DERIVATIVE; TICARCILLIN; UNINDEXED DRUG;

ARTICLE; DOSE RESPONSE; DRUG ACTIVITY; DRUG COST; DRUG TARGETING; DRUG USE; HEALTH CARE POLICY; HEALTH SURVEY; HUMAN; INTENSIVE CARE UNIT; PATIENT CARE; STRATIFICATION; SURGICAL WARD; SUSTAINED DRUG RELEASE; UNIVERSITY HOSPITAL;

EID: 33749005077     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2006.18.4.394     Document Type: Article

References (31)

1. Polk R. Optimal use of modern antibiotics: emerging trends. Clin Infect Dis 1999; 29 (2): 264-274.
2. Goossens H, Ferech M, Vander Stichele R, Elseviers M; ESAC Project Group. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005; 365 (9459): 579-87.
3. Cars O, Molstad S, Melander A. Variation in antibiotic use in the European Union. Lancet 2001; 357 (9271): 1851-1853.
4. de Width K, Bergner J, Buhner J et al. Antibiotic use in German university hospitals 1998-2000 (project INTERUNI-II). Int J Antimicrob Agents 2004; 24 (3): 15-20.
5. Janknegt R, Oude Lashof A, Gould IM, van der Meer JW. Antibiotic use in Dutch hospitals 1991-1996. J Antimicrob Chemother 2000; 45 (2):251-256.
6. Muller-Pebody B, Muscat M, Pelle B, Klein BM, Brandt CT, Monnet DL. Increase and change in pattern of hospital antimicrobial use, Denmark, 1997-2001. J Antimicrob Chemother 2004; 54 (6): 1122-1126.
7. Dancer SJ. How antibiotics can make us sick: the less obvious adverse effects of antimicrobial chemotherapy. Lancet Infect Dis 2004; 4 (10):611-619.
8. Cristino JM. Correlation between consumption of antimicrobials in humans and development of resistant bacteria. Int J Antimicrob Agents 1999; 12 (3): 199-202.
9. Goldmann DA, Weinstein RA, Wenzel RP et al. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals. A challenge to hospital leadership. JAMA 1996; 275 (3): 234-240.
10. White RL, Friedrich LV, Mihm LB, Bosso JA. Assessment of the relationship between antimicrobial usage and susceptibility: differences between the hospital and specific patient-care areas. Clin Infect Dis 2000; 31 (1): 16-23.
11. Naaber P, Koljalg S, Maimets M. Antibiotic usage and resistance - trends in Estonian University Hospitals. Int J Antimicrob Agents 2000; 16 (3): 309-315.
12. Fridkin SK, Steward CD, Edwards JR et al. Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: Project ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals. Clin Infect Dis 1999; 29 (2): 245-252.
13. Natsch S. Collecting, converting and making sense of hospital antimicrobial consumption data. In: Gould IM, van der Meer JWM, eds. Antibiotic Policies. Theory and Practice. New York: Kluwer Academic / Plenum Publishers, 2005; 67-74.
14. th Edition). WHO Collaborating Centre for Drug Statistics Methodology, Oslo, 2002.
15. Wertheimer AI. The defined daily dose system (DDD) for drug utilization review. Hosp Pharm 1986; 21 (3): 233-4, 239-41, 258.
16. Wessling A, Boethius G. Measurement of drug use in a defined population; evaluation of the defined daily dose (DDD) methodology. Eur J Clin Pharmacol 1990; 39 (3): 207-210.
17. Ronning M. Coding and classification in drug statistics - From national to global application. Norwegian J Epidemiol 2001; 11: 37-40.
18. Bager F. DANMAP: monitoring antimicrobial resistance in Denmark. Int J Antimicrob Agents 2000; 14 (4): 271-274.
19. Molstad S, Cars O. Major change in the use of antibiotics following a national programme: Swedish Strategic Programme for the Rational Use of Antimicrobial Agents and Surveillance of Resistance (STRAMA). Scand J Infect Dis 1999; 31 (2): 191-195.
20. Verbrugh HA. Mapping antibiotic use and resistance in the Netherlands: SWAB and NethMap. Neth J Med 2003; 61 (11): 341-342.
21. Meyer E, Jonas D, Schwab F, Rueden H, Gastmeier P, Daschner FD. Design of a surveillance system of antibiotic use and bacterial resistance in German intensive care units (SARI). Infection 2003; 31 (4): 208-215.
22. Kern WV, de With K, Trautmann M, Kern P, Gonnermann C. Glycopeptide use at four university hospitals in southern Germany. Infection 2002; 30 (5): 262-266.
23. Gyssens IC, Geerligs IE, Dony JM et al. Optimising antimicrobial drug use in surgery: an intervention study in a Dutch university hospital. J Antimicrob Chemother 1996; 38 (6): 1001-1012.
24. Rogues AM, Placet-Thomazeu B, Parneix P et al. Use of antibiotics in hospitals in south-western France. J Hosp Infect 2004; 58 (3): 187-192.
25. Mazzeo F, Capuano A, Motola G et al. Antibiotic use in an Italian university hospital. J Chemother 2002; 14 (4): 332-335.
26. Hermosilla Najera L, Canut Blasco A, Ulibarrena Sanz M, Abasolo Osinaga E, Abecia Inchaurregui LC. Trends in antimicrobial utilization at a Spanish general hospital during a 5-year period. Pharmacoepidemiol Drug Saf. 2003; 12: 243-247.
27. Starakis I, Marangos M, Gikas A, Pediaditis I, Bassaris H. Repeated point prevalence survey of nosocomial infections in a Greek university hospital. J Chemother 2002; 14 (3): 272-278.
28. Gikas A, Pediaditis I, Roumbelaki M, Troulakis G, Romanos J, Tselentis Y. Repeated multi-centre prevalence surveys of hospital-acquired infections in Greek hospitals. J Hosp Infect 1999; 41 (1): 11-18.
29. Neonakis I, Gikas A, Scoulica E, Manios A, Georgiladakis A, Tselentis Y. Evolution of aminoglycoside resistance phenotypes of four Gram-negative bacteria: An 8-year survey in a University Hospital in Greece. Int J Antimicrob Agents 2003; 22(5): 526-531.
30. Christidou A, Gikas A, Scoulica E et al. Emergence of vancomycin-resistant enterococci in a tertiary hospital in Crete, Greece: a cluster of cases and prevalence study on intestinal colonisation. Clin Microbiol Infect 2004; 10 (11): 999-1005.
31. Neonakis IK, Scoulica EV, Dimitriou SK, Gikas AI, Tselentis YJ. Molecular epidemiology of extended-spectrum beta-lactamases produced by clinical isolates in a university hospital in Greece: detection of SHV-5 in Pseudomonas aeruginosa and prevalence of SHV-12. Microb Drug Resist 2003; 9 (2): 161-165.